SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-23-303990
Filing Date
2023-12-27
Accepted
2023-12-27 16:07:01
Documents
2
Group Members
ACCESS INDUSTRIES HOLDINGS LLCACCESS INDUSTRIES MANAGEMENT, LLCACCESS INDUSTRIES, LLCCLAL INDUSTRIES LTD.LEN BLAVATNIK

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d287502dsc13da.htm SC 13D/A 112320
2 EX-99.6 d287502dex996.htm EX-99.6 14241
  Complete submission text file 0001193125-23-303990.txt   128432
Mailing Address 3AZRIELI CENTER TRIANGLE TOWER 45 FLOOR TEL AVIV L3 67023
Business Address 3AZRIELI CENTER TRIANGLE TOWER 45 FLOOR TEL AVIV L3 67023 972-3-6075794
Clal Biotechnology Industries Ltd. (Filed by) CIK: 0001468950 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 451 D STREET, 5TH FLOOR BOSTON MA 02210
Business Address 451 D STREET, 5TH FLOOR BOSTON MA 02210 (857) 209-0050
Elicio Therapeutics, Inc. (Subject) CIK: 0001601485 (see all company filings)

IRS No.: 113430072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-93548 | Film No.: 231518010
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)